Final analysis of phase II results with cemiplimab in metastatic basal cell carcinoma after hedgehog pathway inhibitors

02 Apr 2024

K D Lewis, K Peris, A Sekulic, A J Stratigos, L Dunn, Z Eroglu, A L S Chang, M R Migden, S-Y Yoo, K Mohan, E Coates, E Okoye, T Bowler, J-F Baurain, O Bechter, A Hauschild, M O Butler, L Hernandez-Aya, L Licitra, R I Neves, E S Ruiz, F Seebach, I Lowy, P Goncalves 9, M G Fury

Annals of Oncology, 2024 Feb.

Abstract link

Forse può anche interessarti